The Gout & Uric Acid Education Society (GUAES) has added six new educational videos for patients and medical professionals to its library of popular educational videos on gout, highlighting the society’s most important takeaways from the recently released American College of Rheumatology (ACR) Guidelines on Gout Diagnosis and Treatment. Available under the patient and medical professional portals on www.GoutEducation.org, respectively, the latest videos emphasize the need for continuous communication between gout patients and their doctors about their unique treatment plan, to help prevent gout flares and long-term complications from this poorly understood form of inflammatory arthritis.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60699-gout-uric-acid-education-society-guaes-new-videos-on-acr-guidelines
Crosstex International, a subsidiary of Cantel Medical Corp. (NYSE:CMN), and Prestige Ameritech, the only two major U.S.-based medical mask manufacturers have joined forces to bring attention to a glaring void in public health research and policy – that, if addressed, has the potential to more quickly provide a simple, effective tool to mitigate the spread of influenza and other respiratory borne viruses. The awareness campaign comes in response to a new study, “ Exposure to Influenza Virus Aerosols During Routine Patient Care,” published in The Journal of Infectious Diseases, showing that influenza viruses may spread as far as six feet from a person coughing or sneezing, and that some people, referred to as “super spreaders,” may be more likely to spread the virus. The study, supported by the Department of Health and Human Services with a $600,000 research grant, pointed specifically to concerns for healthcare workers being exposed to coughs from sick patients. Yet government research and policy continues to overlook face masks as a feasible protection measure for both the healthcare industry and the general public.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60417-cantel-medical-fitted-mask-infectious-disease-control-public-health-policy
Solta Medical, Inc. (Nasdaq: SLTM), the global market leader in aesthetic skin treatments, today announced the launch of the Simply Smart Rewards Program for Clear + Brilliant laser treatments, the first-ever patient loyalty program in aesthetic laser skin resurfacing.
Clear + Brilliant and Clear + Brilliant Perméa treatments have been shown to help improve skin tone, texture and other subtle signs of aging. The precise laser energy has allowed most consumers to experience immediate and progressive results that last for months, but vary by age, skin condition and how they protect their skin. The treatment takes about 20 minutes, is safe for all skin types and is suitable for men and women.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61178-solta-medical-launches-clear-brilliant-simply-smart-rewards-program
The Preeclampsia Foundation today released the Illustrated Preeclampsia Symptoms Tear Pad, a patient education tool that was developed in collaboration with health services researchers at Northwestern University Feinberg School of Medicine in Chicago, Ill. The tool effectively informs pregnant women, even those with potentially poor literacy, about preeclampsia. Because preeclampsia is a disorder that can have grave consequences for a mother and her unborn baby, the goal is for the tool to offer information in a way that allows women to assimilate and retain knowledge related to preeclampsia, leading them to promptly seek medical attention should they have symptoms related to preeclampsia.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61626-preeclampsia-foundation-illustrated-symptoms-tear-pad-for-pregnant-women
The Cone doesnt follow the norm when it comes to shape, but dont be fooled, the handsfree design will leave you more than satisfied. The innovative shape hits all the spots and the funky, contemporary style means it doesnt need to be hidden away in the bedroom drawer. Enjoy waves of pleasure with 16 automated programmes including an orgasm button for the less patient. Great fun to use on your own or even more fun for two. We hope you have as much fun with it as we have
The number of gout patients is rising, with an estimated 8.3 million American adults diagnosed with gout—but only 10 percent of them are being properly treated, according to the Gout & Uric Acid Education Society. To heighten awareness and knowledge about gout and to lead to earlier diagnosis and treatment, the society has released two new comprehensive kits to educate patients and provide consistent information for medical professionals. The release of the Take a Stand on Gout Patient Education Kit and Medical Professional Information Kit coincides with Gout Awareness Day, an annual commemoration on May 22 to call attention to the growing incidence of gout and to enhance knowledge so as to improve patient outcomes. Both kits provide new, substantial information about gout from specialists, who treat gout patients every day.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61805-gout-uric-acid-education-society-take-a-stand-on-gout-new-information-kits
Diabetes experts met and determined that some self-monitoring blood glucose (SMBG) systems, despite meeting accuracy standards at the time of U.S. Food and Drug Administration (FDA) clearance, fail to consistently meet accuracy standards once on the market, potentially putting patient health at risk. In a public meeting convened by the Diabetes Technology Society on May 21, 2013, in Arlington, Virginia, leading academic clinicians, clinical chemists, medical device experts, patient advocates and FDA representatives reviewed a growing body of peer-reviewed research demonstrating that the performance of some blood glucose monitors on the market may not be meeting accuracy standards.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61870-diabetes-technology-society-inaccurate-blood-glucose-monitors-risky
Philips Respironics, a unit of Royal Philips (NYSE: PHG, AEX: PHI) and a pioneer in science-based sleep solutions, today announces a significant advancement in sleep therapy with the commercial release of a first of its kind minimal contact nasal mask – Wisp. Designed to fit more than 98% of sleep apnea patients, Wisp brings distinctive styling and patented technology for a better overall mask experience that may improve patient compliance.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62230-philips-respironics-announces-advancement-in-sleep-therapy-with-wisp
Global health service company Cigna is on a mission: to get HopeLab’s cancer-fighting game app Re-Mission 2: Nanobot’s Revenge onto the phones and tablets of every young cancer patient in the world. The free app is available for Android and iOS (Apple) mobile devices.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/62267-cigna-hopelab-re-mission-2-mobile-app
As millions of Americans begin choosing a health plan for the first time under the Affordable Care Act, the new Healthgrades American Hospital Quality Outcomes 2014: Report to the Nation released today reveals how hospital selection can dramatically impact a patient’s health. The report demonstrates that individuals are far more likely to die or suffer complications at hospitals receiving the lowest Healthgrades rating. In fact, each year an estimated 234,252 lives could potentially be saved and 157,418 complications could be avoided if all hospitals performed similarly to the highest rated hospitals.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63942-healthgrades-american-hospital-quality-outcomes-2014-report-to-the-nation
Nearly 90 percent of children and adults with a highly aggressive form of acute lymphoblastic leukemia (ALL) showed no evidence of cancer after receiving a novel, personalized cell therapy that reprograms a patient’s immune system. In pilot studies of bioengineered T cells that attack leukemia, 24 of 27 patients (89%) experienced complete responses within 28 days after treatment. In all, 27 patients received the treatment--22 children treated at The Children’s Hospital of Philadelphia and five adults treated at the Hospital of the University of Pennsylvania.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64394-chop-penn-harness-engineered-t-cells-eliminate-tumors-in-blood-leukemia
With the introduction of Abbott's iDesign Dx system, U.S. ophthalmologists now have a diagnostic tool that can capture five optical measurements in one three-second scan to determine the patient's visual abnormalities. This highly advanced diagnostic tool measures the internal optics and surface of the eye more precisely than conventional methods, allowing doctors to fully evaluate imperfections that result in poor vision. Obtaining these measurements in one three-second scan enables ophthalmologists to screen patients more efficiently to determine if they are eligible for LASIK or other refractive surgery and to assist in diagnosis of other conditions.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64467-abbott-idesign-dx-system-available-for-opthalmologists-and-patients
